The Health Technology Podcast

Kirsten Carroll: How to Develop, Communicate, and Deliver on a Winning Medtech Strategy

Kirsten Carroll, Vice President, Strategic Development, Imperative Care

Kirsten Carroll holds over 15 years of experience in product development, marketing, strategy and business development for medical devices in stroke care. In November 2017, she joined Imperative Care (an Incept Company), working under the leadership of Fred Khosravi. Prior to her new role, Kirsten was the Senior Director of Strategic Development at Stryker Neurovascular, leading business intelligence, NV services products and BD deal modeling and diligence activities. Kirsten’s first 8 years at Stryker Neurovascular (previously Boston Scientific) were spent in a succession of marketing management roles in the access and hemorrhagic stroke franchises. During that tenure she acted as marketing lead on multiple product development teams, the MAPS Trial, and ultimately the Target Coil, which went on to realize over $1B in revenue to-date and remains the #1 embolization coil in the world. Following the neurovascular division’s acquisition by Stryker in 2011, Kirsten moved into Marketing Operations, ultimately building it into a 9-person Strategic Development function that managed business development, portfolio planning and business intelligence. She holds 2 patents on pre-shaped microcatheters and is a contributing author on 3 publications in the American Journal of Neuroradiology. Kirsten earned a B.Sc. in biomedical engineering from Yale University and an MBA and MPH from the Haas School of Business at UC Berkeley.

Michael Seres: From Hacking an Ostomy Sensor to Commercializing a Platform for Patients Worldwide

Michael Seres, Founder & CEO, 11 Health

Michael Seres, the Founder/ CEO of 11 Health and Technologies Limited, was diagnosed with the incurable bowel condition, Crohn's Disease at the age of 12. After over 20 operations and an intestinal failure, Michael became the 11th person to undergo a small bowel transplant at the Churchill Hospital in Oxford, UK, which included becoming a stoma patient. Additionally, Michael is also a 2-time Cancer patient. In 2013, Michael founded the health tech start up 11 health and has developed sensor technology for ostomy patients.

Michael, started blogging about his journey through Bowel Transplant and his blog now has over 100,000 followers. He uses social media to develop global online peer to peer communities: covering over 20,000 patients. He is now the patient lead for the main UK health twitter chat #NHSSM, a member of the NHS England Digital Services user council, a published author and a professional speaker. He is the inaugural e-patient in residence and an executive board member at Stanford Medicine X. Michael helped implement the first skype clinics in Oxford Hospital and is an ambassador to the Doctors 2.0 conference.

Derek Herrera: Lessons on Leadership from a Marine Special Operations Officer

Derek Herrera, Founder & CTO, Spinal Singularity

Former Marine Special Operations Officer now working to create change as an entrepreneur in the medical device Industry. Passionate about utilizing advanced technology to create meaningful products to improve people's lives.

An ethical, hard-working leader with proven performance in building successful teams able to accomplish the most challenging of missions in austere, kinetic environments. Demonstrated capacity in building teams across multiple functional areas. Excels at strategic planning, problem framing, and identifying innovative solutions.

Adam Schoen: How to Secure a Strong IP Position for Your Company

Adam Schoen, Partner, Brown Rudnick

Adam Schoen advises life science and medical device companies regarding implementation of a patent strategy to further business objectives and business goals. Adam’s practice encompasses patent preparation and prosecution, portfolio development, product clearance, freedom to operate analysis and intellectual property due diligence. Adam works with public and private companies, investors, and academic institutions.

Adam has experience with a variety of technologies, such as next generation sequencing technologies, droplet based technologies, cancer diagnostics, medical device technology (ophthalmology, cardiology, orthopedics, neurology, spine) and medical imaging technology (IVUS and OCT), mass spectrometry, small molecule therapeutics, digital health, near field communication technology, and semiconductor technology. He manages patent portfolios of all sizes and develops strategies to maximize and protect intellectual property rights in both the United States and foreign jurisdictions.

Prior to law school, Adam was a scientist of analytical chemistry for ArQule Inc., a combinatorial chemistry and drug discovery company.